About Dennis Bilski
Form D filings for Dracen Pharmaceuticals from 2021 to 2023 list Dennis Bilski as acting chief financial officer.
Dennis Bilski first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Dennis Bilski in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Dennis Bilski works with at each company, as listed on that company's latest Form D.
Dracen Pharmaceuticals, Inc. · Form D, Aug 10, 2023